Hydrophilic, Potent, and Selective 7-Substituted 2-Aminoquinolines as Improved Human Neuronal Nitric Oxide Synthase Inhibitors.
Pensa, A.V., Cinelli, M.A., Li, H., Chreifi, G., Mukherjee, P., Roman, L.J., Martasek, P., Poulos, T.L., Silverman, R.B.(2017) J Med Chem 60: 7146-7165
- PubMed: 28776992 
- DOI: https://doi.org/10.1021/acs.jmedchem.7b00835
- Primary Citation of Related Structures:  
5VUI, 5VUJ, 5VUK, 5VUL, 5VUM, 5VUN, 5VUO, 5VUP, 5VUQ, 5VUR, 5VUS, 5VUT, 5VUU, 5VUV, 5VUW, 5VUX, 5VUY, 5VUZ, 5VV0, 5VV1, 5VV2, 5VV3, 5VV4, 5VV5, 5VV6, 5VV7, 5VV8, 5VV9, 5VVA, 5VVB, 5VVC, 5VVD, 5VVG, 5VVN - PubMed Abstract: 
Neuronal nitric oxide synthase (nNOS) is a target for development of antineurodegenerative agents. Most nNOS inhibitors mimic l-arginine and have poor bioavailability. 2-Aminoquinolines showed promise as bioavailable nNOS inhibitors but suffered from low human nNOS inhibition, low selectivity versus human eNOS, and significant binding to other CNS targets ...